BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Donís SP, González AP, Alves MGO, do Carmo Carvalho BF, Ferreira CCP, Almeida JD, Iruegas EP, Petronacci CMC, Peñaranda JMS, Sayáns MP. MLH1, MSH2, MRE11, and XRCC1 in Oral Leukoplakia and Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol 2021;29:613-8. [PMID: 33734109 DOI: 10.1097/PAI.0000000000000929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lei H, He A, Jiang Y, Ruan M, Han N. Targeting DNA damage response as a potential therapeutic strategy for head and neck squamous cell carcinoma. Front Oncol 2022;12:1031944. [DOI: 10.3389/fonc.2022.1031944] [Reference Citation Analysis]
2 Jin Y, Wang Z, Xiang K, Zhu Y, Cheng Y, Cao K, Jiang J. Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma. Front Genet 2022;13:900911. [DOI: 10.3389/fgene.2022.900911] [Reference Citation Analysis]
3 Padin-iruegas E, Chamorro-petronacci CM, Sines-cajade I, Lorenzo-pouso AI, Blanco-carrión A, Pérez-jardón A, Gándara-vila P, Pérez-sayans M. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization. Medicina 2022;58:878. [DOI: 10.3390/medicina58070878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qiu W, Ding K, Liao L, Ling Y, Luo X, Wang J. Analysis of the Expression and Prognostic Value of MSH2 in Pan-Cancer Based on Bioinformatics. Biomed Res Int 2021;2021:9485273. [PMID: 34859104 DOI: 10.1155/2021/9485273] [Cited by in F6Publishing: 1] [Reference Citation Analysis]